On November 23rd, the FDA granted an EUA for a second antibody vaccine through AstraZeneca. While it’s not available to everyone at this time, many sighed relief for the first time in months. Inoculations have already begun, and hope breaks through the dark clouds that have covered us for almost an entire year. On this momentous occasion, it’s only right that we take pause and applaud the people behind the COVID-19 advancements. The researchers are working around the clock to make this world safe again.
Progress Made Thus Far
The first case in the U.S. is confirmed on January 21st, 2020. Since then, a lot has happened; here are the highlights of 2020:
- March 30th– Hydroxychloroquine is granted EUA, but later was rescinded on June 15th due to heart rhythm patients in some patients.
- May 1st– Remdesivir is granted EUA, which has shown to accelerate recovery in those with advanced COVID-19. It was granted full approval in October.
- August 17th– COVID-19 Now the Third-Leading Cause of Death in the U.S.
- November 9th – Eli Lilly’s monoclonal antibody treatment, bamlanivimab receives a limited use authorization from the FDA.
- November 23rd – FDA grants an EUA for a second COVID-19 antibody treatment. The Regeneron cocktail was what was administered to Trump when he was battling COVID-19.
- December 11th– Pfizer’s mRNA vaccine receives limited FDA approval.
- December 18th – Moderna’s mRNA vaccine receives limited approval from the FDA.
Clinical research studies allow us to learn more about COVID-19 and other diseases. The information learned helps researchers design and improve ways to detect, treat, and prevent these conditions. Thanks to unprecedented funding from programs like Operation Warp Speed, and FDA fast-tracking, researchers nationwide have made treating and preventing this virus a reality.
Along with other federal and local agencies, public health officials, and researchers and volunteers across the country, the FDA continues critical work of protecting the public’s health during the COVID pandemic. The efforts include increasing the availability of tests, treatments, and medical devices such as ventilators and personal protective equipment, and many other essential items. To date, there are over 4300 studies related to COVID-19.
We Still Need Volunteers
Clinical research’s role in the fight to end COVID is often overlooked, especially when there is much more to do before we can say the battle is won. Volunteers participating in clinical research studies make the hope of beating this virus possible.
Our team here at Bandera Family Healthcare Research continues the fight to end COVID-19 with enrolling studies looking into new options. To learn more about how you can get involved in our COVID-19 studies, visit our webpage for more information, or call (210) 296-2445.